Japanese Government Procurement

National University Corporation - Notice of Procurement (Goods & Services)A Durvalumab (Genetical Recombination) (120mg 2.4mL/1vial) 1,720 vials,Ｂ　Agalsidase Alfa (Genetical Recombination) (3.5mg 3.5mL／1vial) 510 vials,Ｃ　Elapegademase (Genetical Recombination) (2.4mg 1.5mL／1vial) 270 vials,Ｄ　Tisagenlecleucel 10 Sets,Ｅ　Onasemnogene abeparvovec 1 Set

This procurement is covered by the WTO Agreement on Government Procurement, Japan-EU Economic Partnership Agreement or Japan-UK Comprehensive Economic Partnership Agreement.

Japanese

Publishing date Mar 26, 2021
Type of notice Notice of Procurement (Goods & Services)
Procurement entity National University Corporation - Hokkaido
Classification
0004 Medical & Pharmaceutical Products
Summay of notice ⑴ Official in charge of disbursement of the procuring entity : HOUKIN Kiyohiro, President, The National University Corporation Hokkaido University
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased :
A Durvalumab (Genetical Recombination) (120mg 2.4mL/1vial) 1,720 vials
B Agalsidase Alfa (Genetical Recombination) (3.5mg 3.5mL/1vial) 510 vials
C Elapegademase (Genetical Recombination) (2.4mg 1.5mL/1vial) 270 vials
D Tisagenlecleucel 10 Sets
E Onasemnogene abeparvovec 1 Set
⑷ Delivery period : From 1 June, 2021 through 31 May, 2022
⑸ Delivery place : Hokkaido University Hospital
⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :
A have the Grade A, Grade B or Grade C qualification during fiscal 2021 in the Hokkaido area in sales of product for participating in tenders by Single qualification for every ministry and agency, or in tenders by Hokkaido University,
B prove to have obtained the first-class license for selling drugs in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices,
C prove to have the ability to deliver the products, required by this notice, on the date and to the place specified by the President,
D not be currently under a suspension of business order as instructed by President, The National University Corporation Hokkaido University.
⑺ Time limit of tender : 17 : 00 17 May, 2021
⑻ Contact point for the notice : Michio Yamauchi, Medicine Section, Financial Division, Hokkaido University Hospital, Kita 13 Nishi 6 Kita-ku Sapporo-shi 060-0813 Japan, TEL 011-706-7405
⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents.